NEXIEN BIOPHARMA, INC. Note Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment and Third Extension of Note Purchase Agreement between Nexien Biopharma, Inc. and Richard Greenberg
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2025
Convertible Promissory Note between Nexien BioPharma, Inc. and Alain Bankier dated November 4, 2024
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2025
Convertible Promissory Note dated October 3, 2024 issued to Quick Capital, LLC
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2024
Note Purchase Agreement dated October 3, 2024 between the Company and Quick Capital, LLC
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2024
Amendment and Second Extension of Note Purchase Agreement between Nexien Biopharma, Inc. and Richard Greenberg
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2024
Convertible Promissory Note between Nexien Biopharma, Inc. and Quick Capital, LLC dated February 14, 2024
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
FL
2024
Note Purchase Agreement between Nexien Biopharma, Inc. and Quick Capital, LLC dated February 14, 2024
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2024
Amendment and Extension of Note Purchase Agreement between Nexien Biopharma, Inc. and Quick Capital, LLC (May 2023)
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2023
Convertible Promissory Note between Nexien Biopharma, Inc. and Quick Capital, LLC dated January 18, 2022
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
FL
2022
Note Purchase Agreement between Nexien Biopharma, Inc. and Quick Capital, LLC dated January 18, 2022
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2022
Convertible Promissory Note between Nexien BioPharma, Inc. and Richard Greenberg dated November 24, 2020
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2021
Demand Convertible Promissory Note between Nexien BioPharma, Inc. and Richard Greenberg dated June 11, 2020
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2020